These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 25721895)
1. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM). Della Porta MG; Tuechler H; Malcovati L; Schanz J; Sanz G; Garcia-Manero G; Solé F; Bennett JM; Bowen D; Fenaux P; Dreyfus F; Kantarjian H; Kuendgen A; Levis A; Cermak J; Fonatsch C; Le Beau MM; Slovak ML; Krieger O; Luebbert M; Maciejewski J; Magalhaes SM; Miyazaki Y; Pfeilstöcker M; Sekeres MA; Sperr WR; Stauder R; Tauro S; Valent P; Vallespi T; van de Loosdrecht AA; Germing U; Haase D; Greenberg PL; Cazzola M Leukemia; 2015 Jul; 29(7):1502-13. PubMed ID: 25721895 [TBL] [Abstract][Full Text] [Related]
2. Improved risk stratification by the integration of the revised international prognostic scoring system with the myelodysplastic syndromes comorbidity index. van Spronsen MF; Ossenkoppele GJ; Holman R; van de Loosdrecht AA Eur J Cancer; 2014 Dec; 50(18):3198-205. PubMed ID: 25454415 [TBL] [Abstract][Full Text] [Related]
3. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS. Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029 [TBL] [Abstract][Full Text] [Related]
5. Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database. Voso MT; Fenu S; Latagliata R; Buccisano F; Piciocchi A; Aloe-Spiriti MA; Breccia M; Criscuolo M; Andriani A; Mancini S; Niscola P; Naso V; Nobile C; Piccioni AL; D'Andrea M; D'Addosio A; Leone G; Venditti A J Clin Oncol; 2013 Jul; 31(21):2671-7. PubMed ID: 23796988 [TBL] [Abstract][Full Text] [Related]
6. Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register. Moreno Berggren D; Folkvaljon Y; Engvall M; Sundberg J; Lambe M; Antunovic P; Garelius H; Lorenz F; Nilsson L; Rasmussen B; Lehmann S; Hellström-Lindberg E; Jädersten M; Ejerblad E Br J Haematol; 2018 Jun; 181(5):614-627. PubMed ID: 29707769 [TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. Zeidan AM; Al Ali N; Barnard J; Padron E; Lancet JE; Sekeres MA; Steensma DP; DeZern A; Roboz G; Jabbour E; Garcia-Manero G; List A; Komrokji R Leukemia; 2017 Jun; 31(6):1391-1397. PubMed ID: 28111463 [TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System. van Spronsen MF; Ossenkoppele GJ; Westers TM; van de Loosdrecht AA Eur J Cancer; 2016 Mar; 56():10-20. PubMed ID: 26798967 [TBL] [Abstract][Full Text] [Related]
9. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification]. Wang XQ; Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053 [TBL] [Abstract][Full Text] [Related]
10. [The prognostic significance of pretransplantation evaluation of IPSS-R and WPSS in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation]. Lu CQ; Hou C; Wang P; Zhang LW; Fan Y; Wu DP; Xu Y Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):247-254. PubMed ID: 35405784 [No Abstract] [Full Text] [Related]
11. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS. Kuendgen A; Nomdedeu M; Tuechler H; Garcia-Manero G; Komrokji RS; Sekeres MA; Della Porta MG; Cazzola M; DeZern AE; Roboz GJ; Steensma DP; Van de Loosdrecht AA; Schlenk RF; Grau J; Calvo X; Blum S; Pereira A; Valent P; Costa D; Giagounidis A; Xicoy B; Döhner H; Platzbecker U; Pedro C; Lübbert M; Oiartzabal I; Díez-Campelo M; Cedena MT; Machherndl-Spandl S; López-Pavía M; Baldus CD; Martinez-de-Sola M; Stauder R; Merchan B; List A; Ganster C; Schroeder T; Voso MT; Pfeilstöcker M; Sill H; Hildebrandt B; Esteve J; Nomdedeu B; Cobo F; Haas R; Sole F; Germing U; Greenberg PL; Haase D; Sanz G Leukemia; 2021 Mar; 35(3):835-849. PubMed ID: 32595214 [TBL] [Abstract][Full Text] [Related]
12. Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides. Zeidan AM; Sekeres MA; Garcia-Manero G; Steensma DP; Zell K; Barnard J; Ali NA; Zimmerman C; Roboz G; DeZern A; Nazha A; Jabbour E; Kantarjian H; Gore SD; Maciejewski JP; List A; Komrokji R; Leukemia; 2016 Mar; 30(3):649-57. PubMed ID: 26464171 [TBL] [Abstract][Full Text] [Related]
13. Revised international prognostic scoring system for myelodysplastic syndromes. Greenberg PL; Tuechler H; Schanz J; Sanz G; Garcia-Manero G; Solé F; Bennett JM; Bowen D; Fenaux P; Dreyfus F; Kantarjian H; Kuendgen A; Levis A; Malcovati L; Cazzola M; Cermak J; Fonatsch C; Le Beau MM; Slovak ML; Krieger O; Luebbert M; Maciejewski J; Magalhaes SM; Miyazaki Y; Pfeilstöcker M; Sekeres M; Sperr WR; Stauder R; Tauro S; Valent P; Vallespi T; van de Loosdrecht AA; Germing U; Haase D Blood; 2012 Sep; 120(12):2454-65. PubMed ID: 22740453 [TBL] [Abstract][Full Text] [Related]
14. Improvement of the WHO classification-based prognostic scoring system (WPSS) by including age for Korean patients with the myelodysplastic syndrome. Kim SH; Lee JH; Choi J; Kwon KA; Lee S; Oh SY; Kwon HC; Han JY; Kim HJ Leuk Res; 2010 Dec; 34(12):1589-95. PubMed ID: 20633929 [TBL] [Abstract][Full Text] [Related]
15. Dynamic assessment of RBC-transfusion dependency improves the prognostic value of the revised-IPSS in MDS patients. Hiwase DK; Singhal D; Strupp C; Chhetri R; Kutyna MM; Wee LA; Harrison PB; Nath SV; Wickham N; Hui CH; Gray JX; Bardy P; Ross DM; Lewis ID; Reynolds J; To LB; Germing U Am J Hematol; 2017 Jun; 92(6):508-514. PubMed ID: 28247421 [TBL] [Abstract][Full Text] [Related]
16. A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study. GenoMed4All consortium Lancet Haematol; 2023 Feb; 10(2):e117-e128. PubMed ID: 36436542 [TBL] [Abstract][Full Text] [Related]
17. Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes. Verburgh E; Achten R; Maes B; Hagemeijer A; Boogaerts M; De Wolf-Peeters C; Verhoef G J Clin Oncol; 2003 Jan; 21(2):273-82. PubMed ID: 12525519 [TBL] [Abstract][Full Text] [Related]
18. [Hematologic response predictor factors in adults with myelodysplastic syndromes (SMD) treated with cyclosporin A (CSA)]. Zamora-Pérez E; López-Karpovitch X Gac Med Mex; 2015; 151(3):345-53. PubMed ID: 26089271 [TBL] [Abstract][Full Text] [Related]
19. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes. Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA Br J Haematol; 2014 Oct; 167(1):100-9. PubMed ID: 24976502 [TBL] [Abstract][Full Text] [Related]
20. Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study. Lee JH; Kim YJ; Sohn SK; Yoon SS; Kim H; Cheong JW; Lee WS; Lee GW; Lim SN; Kim MK; Lee HS; Kim HJ; Leuk Res; 2017 Sep; 60():135-144. PubMed ID: 28826063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]